The AHA today voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer television advertisements and encouraged the agency to “rein in skyrocketing drug prices” for patients and the providers who serve them. “We appreciate CMS’s focus on this issue, and we believe this proposal represents an important first step in bringing more transparency to drug pricing,” AHA wrote. “Further, the specific provisions outlined in this proposed rule are consistent with drug price solutions for which the AHA will continue to advocate.” In the rule, the agency estimates that U.S. prescription drug spending grew to about $457 billion in 2015, almost 17 percent of overall spending on personal health care services. “These numbers continue to grow at an unsustainable rate far above the rate of inflation,” AHA said. “The public has been clear: more than 80 percent of the American public says that prescription drug costs are ‘unreasonable.’ Despite this outcry, drug manufacturers continue to take advantage of a complicated system to extract high prices.” 

Related News Articles

Headline
The Centers for Medicare…
Headline
The AHA Physician Alliance today released a resource to help hospital and health system leaders address burnout in their organizations.
Headline
The AHA has elected to fill a vacancy on its Board of Trustees Sylvia Young, president and CEO of HCA Healthcare’s Continental Division.
Headline
A new AHA issue brief describes how hospitals are investing in affordable housing, based on initial findings from the Accelerating Investments for Healthy…
Headline
The AHA May 16 at 11 a.m. ET will host a Twitter chat as part of National Hospital Week to honor and discuss the many ways that hospital employees provide hope…
Headline
The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released…